SELEX-HTCFQ Platform: Developing DNA Enhancers of ADAR1 to Suppress ZBP1-Dependent Immunopathology
- Journal:
- Journal of the American Chemical Society
- Published:
- DOI:
- 10.1021/jacs.5c18671
- Affiliations:
- 4
- Authors:
- 10
| Institutions | Authors | Share |
|---|---|---|
| State Key Laboratory of Medicinal Chemical Biology (SKLMCB), China | 0.85 | |
| Hainan Medical University, China | 0.05 | |
| Tianjin People's Hospital, China | 0.05 | |
| Tianjin Union Medical Center, China | 0.05 |